Researcher profile
Julio Sanjuán
Affiliations
Organizations
Centro de Investigación Biomédica en Red de Salud Mentalauthorship · ESHospital Clínico Universitario de Valenciaauthorship · ESHospital Virgen de la Luzauthorship · ESINCLIVA Health Research Instituteauthorship · ESInsermauthorship · FRInstitut de Psychiatrie et Neurosciences de Parisauthorship · FRInstituto de Salud Carlos IIIauthorship · ESInstitut Pierre Louis d‘Épidémiologie et de Santé Publiqueauthorship · FRUniversitat de Valènciaauthorship · ES
Public evidence
7 connected articles
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings.2024 · Europe PMCThe Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study.2024 · Europe PMCCannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMCThe association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.2023 · Europe PMCDaily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open AccessSocial disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study.2021 · PubMed Central Open AccessThe contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.2019 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.